Company Profiles

driven by the PitchBook Platform

Alpine Immune Sciences

Description

Developer of novel protein‐based immunotherapies. The company is focused on developing novel protein‐based immunotherapies using its proprietary variant immunoglobulin domain (vIgD™) platform technology. It has also developed transmembrane immunomodulatory protein (TIP™) technology, based on vIgD™, for direct applications with engineered cellular therapies.

2015

Founded

PRIVATE

Status

Series A2

Latest Deal Type

$48M

Latest Deal Amount

$49.3M

Total Amount Raised

3

Investors

Description

Developer of novel protein‐based immunotherapies. The company is focused on developing novel protein‐based immunotherapies using its proprietary variant immunoglobulin domain (vIgD™) platform technology. It has also developed transmembrane immunomodulatory protein (TIP™) technology, based on vIgD™, for direct applications with engineered cellular therapies.

Website:

www.alpineimmunesciences.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

600 Stewart Street Suite 1503 Seattle, WA 98101United States +1 (206) 441-5064
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Alpine Immune Sciences's full profile, request a free trial.

Alpine Immune Sciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Alpine Immune Sciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Alpine Immune Sciences Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alpine BioVenturesOtherMinority000 0000000 0000
Frazier HealthcareGrowth/ExpansionMinority000 0000000 0000
OrbiMedVenture CapitalMinority000 0000000 0000
Alpine BioVentures Other
Frazier Healthcare Growth/Expansion
OrbiMed Venture Capital

Alpine Immune Sciences Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Jay Venkatesan MDPresident & Board Member
David MillerDirector & Secretary
Michael Kornacker Ph.DCo-Founder, SVP Protein Engineering & Board Member
Ryan SwansonCo-Founder, Senior Vice President, Immunology & Board Member
Mitchell Gold MDCo-Founder, Executive Chairman and Acting Chief Executive Officer
Jay Venkatesan MD President & Board Member
David Miller Director & Secretary
Michael Kornacker Ph.D Co-Founder, SVP Protein Engineering & Board Member
Ryan Swanson Co-Founder, Senior Vice President, Immunology & Board Member
Mitchell Gold MD Co-Founder, Executive Chairman and Acting Chief Executive Officer

Alpine Immune Sciences Board Members (4)

NameRepresentingRoleSinceContact
Info
James Topper Ph.DSelfBoard Member000 0000
Jay Venkatesan MDAlpine Immune SciencesPresident & Board Member000 0000
Mitchell Gold MDAlpine Immune SciencesCo-Founder, Executive Chairman and Acting Chief Executive Officer000 0000
Peter Thompson MDOrbiMedPrivate Equity Partner000 0000
James Topper Ph.D Board Member Self
Jay Venkatesan MD President & Board Member Alpine Immune Sciences
Mitchell Gold MD Co-Founder, Executive Chairman and Acting Chief Executive Officer Alpine Immune Sciences
Peter Thompson MD Private Equity Partner OrbiMed
Request full access to PitchBook